Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / HTBX - Heat Bio unveils RapidVax vaccine platform targeting emerging biological threats

HTBX - Heat Bio unveils RapidVax vaccine platform targeting emerging biological threats

Heat Biologics Inc.
Heat Biologics (NASDAQ:HTBX) has unveiled its new RapidVax cellular vaccine platform at the 2021 World Antiviral Congress. Shares up 5.8% premarket at $4.60. RapidVax is designed to enable an accelerated response to a wide variety of infectious agents by providing a flexible “plug and play” vaccine platform that can be stockpiled in advance, and then rapidly customized, manufactured, and deployed to address imminent and future biological threats. This platform has the potential to shorten the timelines needed to develop and test novel vaccines against emerging infectious agents.

For further details see:

Heat Bio unveils RapidVax vaccine platform targeting emerging biological threats
Stock Information
Company Name: Heat Biologics Inc.
Stock Symbol: HTBX
Market: NASDAQ
Website: heatbio.com
Menu
HTBX HTBX Quote HTBX Short HTBX News HTBX Articles HTBX Message Board
Get HTBX Alerts

News, Short Squeeze, Breakout and More Instantly...